Finally, treatment with low-dose IL-2 increases Treg number and function, and adoptive transfer of IL-2-induced Tregs is neuroprotective along the nigrostriatal axis in MPTP-treated mice, thus providing another promising Treg-inducing strategy for PD [101]. Here, IL2 is linked to Parkinson disease.